Tejnaksh Healthcare Limited (BOM:539428)
India · Delayed Price · Currency is INR 13.25
+0.09 (0.68%)
At close: Aug 21, 2026
Tejnaksh Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 12.28 | 23.28 | 17.76 | 16.83 | 27.24 |
Depreciation & Amortization | 14.28 | 9.1 | 9.06 | 8.7 | 6.48 |
Other Amortization | - | 0 | 0 | 0.04 | - |
Loss (Gain) From Sale of Assets | 0.11 | - | - | - | 0.45 |
Provision & Write-off of Bad Debts | 0.75 | 0.18 | 5.48 | 0.65 | 1.47 |
Other Operating Activities | -6.25 | 6.78 | 7.12 | 17.25 | 17.2 |
Change in Accounts Receivable | -4.01 | -13.43 | 5.06 | -10.75 | -2.48 |
Change in Inventory | -0.42 | 0.19 | -1.43 | 0.56 | -0.25 |
Change in Accounts Payable | -0.59 | 0.77 | -3.22 | 1.57 | -0.8 |
Change in Other Net Operating Assets | 1 | -23.03 | 0.27 | -13.61 | 42.78 |
Operating Cash Flow | 17.16 | 3.83 | 40.09 | 21.23 | 92.08 |
Operating Cash Flow Growth | 347.64% | -90.44% | 88.84% | -76.95% | 678.56% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -5.15 | -2.48 | -7.06 | -8.26 | -90.77 |
Sale of Property, Plant & Equipment | 0.23 | - | - | 0.08 | 0.46 |
Sale (Purchase) of Intangibles | - | 11.31 | -1.2 | -1.11 | -0.9 |
Investment in Securities | - | - | - | - | -15.29 |
Other Investing Activities | 2.09 | 26.38 | -1.87 | -4.75 | 0.62 |
Investing Cash Flow | -2.83 | 35.21 | -10.13 | -14.04 | -105.88 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Long-Term Debt Issued | - | - | - | - | 50.18 |
Total Debt Issued | - | - | - | - | 50.18 |
Short-Term Debt Repaid | -4.21 | - | - | - | -0.04 |
Long-Term Debt Repaid | -7.22 | -34.93 | -16.4 | -6.03 | -29.01 |
Total Debt Repaid | -11.42 | -34.93 | -16.4 | -6.03 | -29.05 |
Net Debt Issued (Repaid) | -11.42 | -34.93 | -16.4 | -6.03 | 21.13 |
Other Financing Activities | -0.96 | -3.76 | -6.3 | -5.92 | -4.95 |
Financing Cash Flow | -12.38 | -38.69 | -22.7 | -11.96 | 16.19 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | - | 0 |
Net Cash Flow | 1.94 | 0.35 | 7.27 | -4.77 | 2.39 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 12.01 | 1.35 | 33.03 | 12.96 | 1.31 |
Free Cash Flow Growth | 787.00% | -95.90% | 154.76% | 892.65% | -82.34% |
Free Cash Flow Margin | 11.13% | 1.04% | 26.95% | 10.92% | 1.03% |
Free Cash Flow Per Share | 0.60 | 0.07 | 1.63 | 0.64 | 0.06 |
Levered Free Cash Flow | 22.27 | 11.07 | 26.07 | 3.73 | -60.89 |
Unlevered Free Cash Flow | 22.87 | 13.43 | 30.07 | 7.53 | -58.38 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 0.96 | 3.76 | 6.3 | 5.92 | 4.94 |
Cash Income Tax Paid | 8.38 | 4.7 | 3.35 | -4.21 | -2.39 |
Change in Working Capital | -4.02 | -35.5 | 0.67 | -22.24 | 39.25 |